ClinicalTrials.gg
RecruitingNCT06127264CuffForceUpdated Oct 21, 2026

Reliability of Force Measurement Within the Carbon Fiber Orthosis Proximal Cuff

An interventional study of Carbon Fiber Custom Dynamic Orthosis (CDO) in Healthy, Ankle Foot Orthosis (AFO) and Peripheral Neuropathy, sponsored by University of Iowa. Recruiting at 1 site in United States. Open to participants aged 18 Years to 90 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-21.

Sponsored by University of Iowa · Not applicable, Interventional, and Other

How we know

From the registry’s dates

  • Started Mar 2024; still recruiting 2 years 8 months later.
Updated Oct 21, 2026Primary completion movedStudy completion movedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years to 90 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 191 studies in Peripheral Nervous System Diseases with a site in United States — 31 open to participants now, 48 under way, 2 of them phase 3. Peripheral Nervous System Diseases · United States.

Planned enrollment
50th of 157
60 · median 43
Started
2024
with 4 others
No phase
91 of 191
19 open now
Primary completion
2027-12
later than 29 of 46 live
Registered
169th of 191
by date

Among the 191 studies in Peripheral Nervous System Diseases with a site in United States, this one is the 50th largest by planned enrollment of the 157 interventional ones that give a count, is one of 5 that started in 2024, is one of 91 with no phase, reaches primary completion later than 29 of the 46 other live ones, and was the 169th registered.

Peripheral Nervous System Diseases

476 studies on the registry are indexed under Peripheral Nervous System Diseases; 103 are open to participants now.

Browse Peripheral Nervous System Diseases studies →

Open to participants now

31 of the 191 studies in Peripheral Nervous System Diseases with a site in United States are open now. Recruiting first, the newest first:

25 more — sign in →

All 31 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 65 Peripheral Nervous System Diseases studies recruiting now, 44 (68%) set no upper age limit and 10 (15%) stop at 75 or younger; 8 take children under 18; 10 take healthy volunteers.

This study: 18 Years to 90 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 191 studies in Peripheral Nervous System Diseases with a site in United States, or all of them as a file.
02

Study summary

The primary purpose of this research study is to determine if forces within carbon fiber custom dynamic orthoses (CDOs) can be reliability assessed using Loadpad and Loadsol force measuring sensors (Novel GMBH, St. Paul, MN). An improved understanding of the forces acting within orthoses may help to guide future orthosis related research studies, provision methods, and patient education.

Study participants will consist of three groups; 1) healthy, able-bodied adult participants using generic sized CDOs, which consist of a proximal cuff that wraps around the leg just below the knee, a posterior carbon fiber strut that runs the length of the leg and bends to store and return energy, and a semi-rigid footplate that acts as a lever arm to bend the posterior strut, 2) individuals without peripheral neuropathy who use AFO(s) regularly, and 3) individuals with peripheral neuropathy who use AFO(s) regularly. .

Group 1 participants will be asked to fasten the proximal cuff to a self-selected cuff tightness 'SSCT', as well as three different predefined force levels; 'Loose' where the proximal cuff is loosely fastened around the participants leg, 'Moderate' where the proximal cuff is fastened with moderate tightness, and 'Tight' where the proximal cuff is tightly fastened around the participants leg. Testing in the predetermined force levels (Loose, Moderate, Tight) will occur in a randomized order. Group 2 and Group 3 participants will be asked to fasten their AFO(s) to a self-selected 'SSCT' tightness.

For all groups, forces acting on the leg, within the proximal cuff, will be measured using wireless Loadpad sensors and forces acting on the foot will be measured using wireless Loadsol insoles. Testing will include collection of force data as participants sit quietly, stand quietly, and walk and completion of questionnaires.

Read the detailed description

Ankle foot orthoses (AFOs) are medical devices often used to support the foot and ankle during daily activities. Carbon fiber custom dynamic orthoses (CDOs), one subset of AFOs, that consist of a proximal cuff that wraps around the leg just below the knee, a posterior carbon fiber strut that runs the length of the leg and bends to store and return energy during gait, a semi-rigid carbon fiber footplate that acts as a lever arm to bend the posterior strut, and in some cases a foam heel wedge placed between the footplate and the shoe. Different CDO design characteristics, such as posterior strut stiffness, device alignment, and heel cushion height and stiffness have been studied in the past. While different design characteristics have been studied previously, there is little information available concerning the proximal cuff and how it impacts patient outcomes. Different types of AFOs and CDOs have been used in an effort to offload the limb for years. Both CDOs and patellar tendon bearing (PTB) style AFOs have been shown to reduce forces acting on the plantar surface of the foot. While multiple studies have indicated the importance of fastening the proximal cuff, few have actually investigated the forces acting within the proximal cuff. A loose proximal cuff has been associated with pistoning of the limb, where the limb translates down within the proximal cuff during loading, potentially increasing forces acting on the foot and reducing the offloading effects of the orthosis. Only one study investigated the effects of altering forces within the proximal cuff by adding more padding to the proximal cuff, which was shown to improve limb offloading.

A better understanding of the forces acting within the proximal cuff, and how these effect patient outcomes would help to guide future AFO related research studies, provision, and patient education. At this point in time there is little guidance available to inform patients how tightly they need to secure the proximal cuff when wearing an AFO, many clinicians recommend tightening it so that it's secure, but not uncomfortable. The ability to measure forces within the proximal cuff and an idea of the range of forces seen in a clinical setting will act as a first step to better understanding how forces acting within the proximal cuff impact patient outcomes.

03

Conditions studied

  • Healthy
  • Ankle Foot Orthosis (AFO)
  • Peripheral Neuropathy

Keywords

  • Ankle Foot Orthosis
  • Carbon Fiber Orthosis
  • Plantar Force
04

Who can participate

Ages eligible
18 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

Group 1 - Able Bodied Participants

Inclusion Criteria

  • Between the ages of 18 and 65
  • Healthy without current complaint of lower extremity pain, spine pain, open wounds or active infections, or medical or neuromusculoskeletal disorders that have limited their participation in work or exercise in the last 6 months
  • Able to hop without pain
  • Able to perform a full squat without pain
  • Ability to read and write in English and provide written
  • Ability to fit in a generic sized CDO

Exclusion Criteria

  • Diagnosed with a moderate or severe brain injury
  • Lower extremity injury resulting in surgery or limiting function for greater than 6 weeks
  • Injuries that would limit performance in this study
  • Diagnosed with a physical or psychological condition that would preclude functional testing (e.g. cardiac condition, clotting disorder, pulmonary condition)
  • Visual or hearing impairments that limit walking ability or limit the ability to comply with instructions given during testing
  • Require use of an assistive device
  • Unhealed wounds (cuts/abrasions) that would prevent AFO use
  • > 40
  • Pregnancy

Group 2 - AFO Users without Peripheral Neuropathy

Inclusion Criteria:

  • Between the ages of 18 and 90
  • Use an AFO(s) for daily activities
  • The AFO(s) proximal cuff is compatible with loadpad sensors
  • Have used their AFO(s) for a minimum of 2 weeks
  • Ability to walk 50 feet without use of an assistive device (e.g. cane, crutch, etc.)
  • Ability to read and write in English and provide written informed consent

Exclusion Criteria

  • Diagnosis or indication of peripheral neuropathy determined using Semmes Weinstein Filaments
  • Medical or psychological condition that would preclude functional testing (ex. Moderate or severe brain injury, stroke, heart disease)
  • Requirement of a knee stabilizing device (e.g. KAFO, KO) to preform daily activities
  • Visual or hearing impairments that limit walking ability or limit the ability to comply with instructions given during testing
  • BMI > 40
  • Pregnancy

Group 3 - AFO Users with Peripheral Neuropathy

Inclusion Criteria:

  • Between the ages of 18 and 90
  • Use an AFO(s) for daily activities
  • The AFO(s) proximal cuff is compatible with loadpad sensors
  • Have used their AFO(s) for a minimum of 2 weeks
  • Ability to walk 50 feet without use of an assistive device (e.g. cane, crutch, etc.)
  • Diagnosis or indication of peripheral neuropathy determined using Semmes Weinstein Filaments
  • Ability to read and write in English and provide written informed consent

Exclusion Criteria

  • Medical or psychological condition that would preclude functional testing (ex. Moderate or severe brain injury, stroke, heart disease)
  • Requirement of a knee stabilizing device (e.g. KAFO, KO) to preform daily activities
  • Visual or hearing impairments that limit walking ability or limit the ability to comply with instructions given during testing
  • BMI > 40
  • Pregnancy
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Participant)
Enrollment
60 participants (estimated)

Study arms

  • No intervention
    NoCDO

    Participants will complete study activities without wearing a CDO

  • Experimental
    SSCT

    Participants will complete study activities while wearing a CDO fastened to their self-selected proximal cuff tightness

    Device: Carbon Fiber Custom Dynamic Orthosis (CDO)

  • Experimental
    Loose

    Participants will complete study activities while wearing a CDO fastened to a loose proximal cuff tightness

    Device: Carbon Fiber Custom Dynamic Orthosis (CDO)

  • Experimental
    Moderate

    Participants will complete study activities while wearing a CDO fastened to a moderate proximal cuff tightness

    Device: Carbon Fiber Custom Dynamic Orthosis (CDO)

  • Experimental
    Tight

    Participants will complete study activities while wearing a CDO fastened to a tight proximal cuff tightness

    Device: Carbon Fiber Custom Dynamic Orthosis (CDO)

Interventions

  • DeviceCarbon Fiber Custom Dynamic Orthosis (CDO)

    The carbon fiber custom dynamic orthosis (CDO) will consist of a semi-rigid carbon fiber footplate, a carbon fiber posterior strut, and a proximal cuff that wraps around the leg below the knee that is fastened to different tightness's

    Also known as: Ankle Foot Orthosis (AFO)

06

What researchers measure

Primary outcomes

  1. Proximal Cuff Force

    Proximal cuff forces (N) will be measured as participants sit, stand, and walk without a CDO and in each CDO condition.

    Time frame: Baseline

  2. Peak Plantar Force

    Plantar forces (N) will be measured across the total foot, the hindfoot, midfoot, and forefoot as participants sit, stand, and walk without a CDO and in each CDO condition.

    Time frame: Baseline

  3. Plantar Force Impulse

    Plantar force impulse (Ns) across the total foot, the hindfoot, midfoot, and forefoot will be calculated using the integral of the force over the stance phase as participants sit, stand, and walk without a CDO and in each CDO condition.

    Time frame: Baseline

  4. Numerical Pain Rating Scale

    Pain will be assessed using a standard 11-point numerical pain rating scale, in which 0 = no pain and 10 = worst pain imaginable

    Time frame: Baseline

  5. Modified Socket Comfort Score (Comfort)

    Comfort scores range from 0 = most uncomfortable to 10 = most comfortable

    Time frame: Baseline

Secondary outcomes

  1. Modified Socket Comfort Score (Smoothness)

    Smoothness scores range from 0 = least smooth to 10 = most smooth

    Time frame: Baseline

07

Study locations

1 of 1 sites recruiting
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Mar 2024 (actual). Primary completion is estimated for Dec 2027, 45 months after the start.

Of 122 non-industry interventional studies with no phase under Peripheral Nervous System Diseases, half reached primary completion within 25 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 43. This study's planned 45 months is above that.

Counting every sponsor, half of 132 studies reached it within 25 months; a quarter within 12 and three quarters within 43.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 21, 2026: primary completion Dec 2026 → Dec 2027 and completion Dec 2026 → Dec 2027.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Nov 6, 2023
First posted
Nov 13, 2023
StartActual
Mar 1, 2024
Primary completionEst.
Dec 31, 2027was Dec 2026
CompletionEst.
Dec 31, 2027was Dec 2026
Last update
Oct 21, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Primary completion
Dec 31, 2026→Dec 31, 2027
Oct 21, 2026
Study completion
Dec 31, 2026→Dec 31, 2027
Oct 21, 2026
Show all 1 update
  1. Oct 21, 2026
    Primary completion Dec 31, 2026→Dec 31, 2027
    Study completion Dec 31, 2026→Dec 31, 2027
    + 2 other changes: verification date and contact details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06127264
Lead sponsor
University of Iowa
Responsible party
Jason Wilken (Associate Professor, University of Iowa) — Principal investigator
First posted
Nov 13, 2023
Start date
Mar 1, 2024
Primary completion
Dec 31, 2027 (estimated)
Completion
Dec 31, 2027 (estimated)
Last update
Oct 21, 2026

Study contacts

Jason M Wilken, PT, PhD
Contact
jason-wilken@uiowa.edu
3193356857
Kirsten M Anderson, PhD
Contact
kirsten-m-anderson@uiowa.edu
3193530431
Jason M Wilken, PT,PhD
principal investigator · University of Iowa

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion